Ask AI

Empowered for Change: Why Brain Health Belongs in the OB/GYN Visit

Clinical Thought
Clinical Thought Start Activity
This activity is available for 0.25 CME/CE credit(s).

Released: August 25, 2026

Expiration: August 24, 2027

See Activity Collection

Alzheimer’s disease–related brain changes can begin years to decades before clinical symptoms emerge, placing midlife care at an important point for brain health conversations. This expert commentary examines the important role of OB/GYN HCPs in Alzheimer’s disease prevention and early recognition. It explores the evolving evidence connecting menopause and dementia risk, including menopause-related cognitive changes, the role of menopausal hormone therapy, and modifiable risk factors relevant to OB/GYN practice. It also discusses emerging advances in Alzheimer disease detection and treatment, focusing on how they may influence counseling, evaluation, and referral of patients with cognitive concerns.

AD Detection in OBGYN

Pre Assessment

Assess your current knowledge and clinical approach before beginning your ClinicalThought.
1.

How many people with AD do you provide care for in a typical week?

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

Your 48-year-old patient has begun having irregular periods (longer cycles) and night sweats. She is interested in menopausal hormone therapy (MHT) and asks whether this can help reduce "brain fog" and dementia risk as well. How would you respond to provide the best information to your patient?